“…Oral administration caused some anomalies of the genito-urinary tract and of the heart (Nolen et Scharpf et al, 1972), but was much less toxic than injection, since more than half of the fetuses survived an oral administration by intubation of 80 mg/ kg/ day from days 6 to 19 of pregnancy. Intravenous or intraperitoneal injection of 1-2 mg/kg to rats on days 9-11 elicited hydrocephaly, microphthalmy and anophthalmy (Barr, 1973;Samarawickrama and Webb, 1979), except in the Holtzman strain, where only stunting of the head region was observed (Parzyk et al, 1978). Abnormalities, such as micrognathy or small lung size, were most frequent after s.c. injection of 12 mg on day 14 or IS (Chernoff, 1973), but it should be recalled in this context that at this time of gestation, the placenta is barely permeable to cadmium, and that some effects may also result from an impaired supply of nutrients due to cadmium-induced damage of the placenta (Chiquoine, 1965;Parizek, 1963).…”